Renovaro Inc. reported a net income of $189,176 for the three months ended March 31, 2025, a substantial improvement compared to a net loss of $(58,990,070) in the same period last year. This positive shift was primarily due to a significant change in the fair value of contingent consideration and a decrease in overall operating expenses, despite no revenue generation.

Renovaro Inc. reported a net loss of $7,252,394 for the three months ended December 31, 2024, an increase of 60% from the prior year. Total operating expenses rose by 6% to $4,546,316, primarily driven by an increase in general and administrative expenses, partially offset by a decrease in research and development expenses. The company's cash and cash equivalents stood at $311,764 as of December 31, 2024.